Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01667250 · ClinicalTrials.gov registry record · NA

Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

A NA study of Chronic Migraine, sponsored by ElectroCore.

Completed
Registry status
NA
Development phase
59
Enrollment target
6
Study locations

NCT01667250 is a NA study of Chronic Migraine that has completed, run by ElectroCore. The registered enrollment target is 59 participants, below the 340-participant average among 17 other Chronic Migraine trials with a reported enrollment target (83% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01667250, a NA study of Chronic Migraine, has completed, sponsored by ElectroCore.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target
6
Study locations

Study Summary

The purpose of this multi-center, prospective, double-blind, randomized, sham-controlled pilot study is to study feasibility and collect preliminary clinical data related to the safety and clinical benefits of daily use of non-invasive vagal nerve stimulation with the GammaCore device for the prevention of chronic migraine, and to support the development and approval of a larger pivotal study.

Conditions Studied

Chronic Migraine

Interventions

  • DEVICE GammaCore Active Device
  • DEVICE GammaCore Sham Device

Study Locations (6)

California

  • UCSF Headache Center - San Francisco

Michigan

  • Michigan Head Pain & Neurological Institute - Ann Arbor

Missouri

  • Headache Care Center - Springfield

New York

  • Montefiore Headache Center - The Bronx

North Carolina

  • Carolina Headache Institute - Chapel Hill

Pennsylvania

  • Thomas Jefferson Headache Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2012-10
Est. Completion 2014-05
Phase NA

Sponsor

ElectroCore

6 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01667250

The ClinicalTrials.gov registry entry for NCT01667250 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 340-participant average among 17 other Chronic Migraine trials with a reported enrollment target (83% lower). The listed sponsor is ElectroCore, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Migraine appearing as the primary indexed condition, and to 2 interventions - of which GammaCore Active Device is the first listed.

NCT01667250 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Michigan, Missouri.

Frequently Asked Questions

What is clinical trial NCT01667250 about?

NCT01667250 is a clinical study titled "Non-Invasive Neurostimulation for the Prevention of Chronic Migraine". The purpose of this multi-center, prospective, double-blind, randomized, sham-controlled pilot study is to study feasibility and collect preliminary clinical data related to the safety and clinical benefits of daily use of non-invasive vagal nerve stimulation with the GammaCore device for the preven...

What is the current status of trial NCT01667250?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2012-10. Estimated completion is 2014-05.

What conditions does trial NCT01667250 study?

This clinical trial studies the following conditions: Chronic Migraine.

What interventions are being tested in trial NCT01667250?

The interventions under investigation include: GammaCore Active Device (DEVICE), GammaCore Sham Device (DEVICE).

Who is sponsoring clinical trial NCT01667250?

This trial is sponsored by ElectroCore, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01667250 being conducted?

This trial has 6 study locations across California, Michigan, Missouri, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Migraine

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.